Novartis will present data from studies across its neuroscience portfolio, including seven─year disability outcomes and safety data from the ALITHIOS o...
Mallinckrodt Competitors or Alternatives
Mallinckrodt's top competitors include Endo, JM and Mylan.
Mallinckrodt VS Endo
Endo is Mallinckrodt's #1 competitor. Endo is a Public company that was founded in 1997 in Malvern, Pennsylvania. Endo is in the Pharmaceuticals industry. Compared to Mallinckrodt, Endo has 416 more employees.
Looking for similar companies to Mallinckrodt?
Similar Companies
Pharmaceuticals companies in County Dublin
See 31 companies
Companies in Dublin with revenue in $1.0-5.0B rangeSee 34 companies
Pharmaceuticals & Biotechnology companies in County DublinSee 54 companies
Companies in Ireland with revenue in $1.0-5.0B rangeSee 51 companies
Companies in County Dublin with revenue in $1.0-5.0B rangeSee 41 companies
Companies in County Dublin with employees in 1.0-5.0K rangeSee 64 companies
Companies in Dublin with employees in 1.0-5.0K rangeSee 64 companies
Pharmaceuticals companies in DublinSee 85 companies
Companies in Ireland with employees in 1.0-5.0K rangeSee 102 companies
Trending News for Mallinckrodt and Mallinckrodt's Competitors
The US Food and Drug Association (FDA) has granted fast track designation to Sanofi's mRNA vaccine candidate for the prevention of chlamydia infection....
TEL AVIV, Israel, March 27, 2025 (Korea Bizwire) - Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today that it will issue a press...
A flag flies above the headquarters campus of Eli Lilly and Company on March 17, 2024 in Indianapolis, Indiana. - Image: Scott Olson / Staff (Getty Ima...
The regimen was approved by the MHRA earlier this month to treat EGFR-mutated NSCLC...
The vaccine protects against the serotypes responsible for the majority of adult invasive pneumococcal disease...
read more...
RIPSA interests repurchasedTerm loan facility increased to $450 million with more favorable termsAccess to up to an additional $200 millionLONDON and R...
BridgeBio's acoramidis wins Japan's approval for ATTR-CM. Phase 3 data show a 42% reduction in key heart-related events. AstraZeneca's Alexion to marke...
Recommendation based on Phase 3 CheckMate -77T trial showing significant event-free survival improvement when compared to neoadjuvant chemotherapy and ...
Frequently Asked Questions about Mallinckrodt
Who are Mallinckrodt's top competitors?
Mallinckrodt's top 3 competitors are Endo, JM, Mylan.Who is similar to Mallinckrodt?
Endo is the most similar to Mallinckrodt. JM and Mylan are also similar to Mallinckrodt.
Are Mallinckrodt and Endo competitors?
Yes, Endo is one of Mallinckrodt’s top competitors.